Artking Global Limited reduced its holdings in SIMCERE PHARMA (02096) by 14 million shares at a price of HK$6.1 per share.
On November 14, Artking Global Limited reduced its holdings of Sinopharm Group (02096) by 14 million shares, at a price of 6.1 Hong Kong dollars per share, with a total amount of 85.4 million Hong Kong dollars.
According to the latest information from the Hong Kong Stock Exchange, on November 14, Artking Global Limited reduced its holdings of SIMCERE PHARMA (02096) by 14 million shares, with a price of 6.1 Hong Kong dollars per share, for a total amount of 85.4 million Hong Kong dollars. After the reduction, the latest number of holdings is approximately 1.788 billion shares, with a new shareholding percentage of 70.75%.
Related Articles
JAKOTA CAPITAL (01468) issues profit warning, expecting annual loss not exceeding HK$150 million, an increase of no more than 22% year-on-year.
CHINA HONGBAO (08316) announces annual results, with a net profit of 4.641 million Hong Kong dollars for the year, turning a loss into a profit compared to the previous year.
OUC Holdings (08067) has subscribed for convertible notes with a total face value of 1 million Australian dollars.
JAKOTA CAPITAL (01468) issues profit warning, expecting annual loss not exceeding HK$150 million, an increase of no more than 22% year-on-year.
CHINA HONGBAO (08316) announces annual results, with a net profit of 4.641 million Hong Kong dollars for the year, turning a loss into a profit compared to the previous year.
OUC Holdings (08067) has subscribed for convertible notes with a total face value of 1 million Australian dollars.
RECOMMEND
